| P50 | author | Wolfram Hoetzenecker | Q112308972 |
| | Reinhard Dummer | Q32650033 |
| P2093 | author name string | Lars E French | |
| | Urs Schanz | |
| | Antonio Cozzio | |
| | Gayathri Nair | |
| | Emmanuella Guenova | |
| | Marie-Charlotte Brüggen | |
| | Susanne Kimeswenger | |
| | Florentia Dimitriou | |
| P2860 | cites work | Evaluation of haematopoietic stem cell transplantation in patients diagnosed with cutaneous T-cell lymphoma at a tertiary care centre: should we avoid chemotherapy in conditioning regimes? | Q90179245 |
| | Mycosis Fungoides and Sézary Syndrome: An Update | Q93374418 |
| | European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2017. | Q30235003 |
| | WHO-EORTC classification for cutaneous lymphomas | Q34391006 |
| | Allogeneic hematopoietic cell transplantation for mycosis fungoides and Sezary syndrome | Q34459010 |
| | Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment | Q34633209 |
| | Graft-versus-lymphoma effect in refractory cutaneous T-cell lymphoma after reduced-intensity HLA-matched sibling allogeneic stem cell transplantation | Q35852262 |
| | Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management | Q36470196 |
| | Allogeneic stem-cell transplantation in patients with cutaneous lymphoma: updated results from a single institution | Q36865042 |
| | Review of the treatment of mycosis fungoides and sézary syndrome: a stage-based approach | Q37146595 |
| | Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model | Q37163606 |
| | Long-term outcomes of 1,263 patients with mycosis fungoides and Sézary syndrome from 1982 to 2009. | Q37379370 |
| | Allogeneic stem cell transplantation for advanced cutaneous T-cell lymphomas: a study from the French Society of Bone Marrow Transplantation and French Study Group on Cutaneous Lymphomas | Q37618920 |
| | Hematopoietic Stem Cell Transplant for Mycosis Fungoides and Sézary Syndrome | Q38598537 |
| | New insights into folliculotropic mycosis fungoides (FMF): A single-center experience | Q39721985 |
| | Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects | Q40706569 |
| | Mycosis fungoides and Sezary syndrome. | Q41138272 |
| | Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation | Q44189739 |
| | Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases | Q44988691 |
| | Allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. | Q45886829 |
| | Incidence and survival patterns of cutaneous T-cell lymphomas in the United States | Q46778060 |
| | Allogeneic hematopoietic stem cell transplantation for refractory mycosis fungoides (MF) and Sezary syndrome (SS). | Q50648910 |
| | A meta-analysis of patients receiving allogeneic or autologous hematopoietic stem cell transplant in mycosis fungoides and Sézary syndrome. | Q53384690 |
| | Type I-IFNs control GVHD and GVL responses after transplantation | Q57252624 |
| | Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides: evidence of a graft-versus-tumor effect | Q73399828 |
| | Mycosis fungoides: disease evolution and prognosis of 309 Dutch patients | Q73684481 |
| | Graft versus lymphoma effect after early relapse following reduced-intensity sibling allogeneic stem cell transplantation for relapsed cytotoxic variant of mycosis fungoides | Q80521870 |
| | Allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning for mycosis fungoides and Sezary syndrome | Q85777802 |
| | Long-term outcome of allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and Sézary syndrome: a European society for blood and marrow transplantation lymphoma working party extended analysis | Q87653957 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 290 | |
| P577 | publication date | 2020-06-25 | |
| P1433 | published in | Frontiers in Medicine | Q27726181 |
| P1476 | title | Long-Term Disease Control After Allogeneic Hematopoietic Stem Cell Transplantation in Primary Cutaneous T-Cell Lymphoma; Results From a Single Institution Analysis | |
| P478 | volume | 7 | |